The cost-to-efficacy ratio, given the lack of Phase 3 human data, makes it a lower-priority choice compared to Retatrutide for anyone whose primary goal is meaningful fat loss
How to Choose Which is Right for You For most people, the answer isn't "one or the other," but rather "how do I use them together?" However, your lifestyle can provide clues about where to start
We work with you to develop an exit strategy that protects your results
Yet as prescriptions continue to expand beyond high-risk diabetes Read More Will Generic GLP-1 Drugs Change Diabetes Care
The review highlights its pleiotropic beneficial effects in tissue injury, inflammatory bowel disease, and CNS disorders, and concludes that BPC-157 demonstrates a favorable safety profile with few reported side effects, positioning it as a candidate for further clinical investigation
Weight Loss Use and Age Considerations Beyond FDA Label Ozempic is not FDA-approved for weight loss in any age group, though similar compounds like Wegovy (semaglutide) carry explicit weight management approval for adults 18 and older